
    
      This is a random, double blind placebo -vehicle- controlled study. Patients recruiting and
      inclusion into the study is well defined. Expert on site monitoring will assure execution of
      all assignments as detailed in the protocol (screening, consent form, double-blind group
      assignment) .

      Statistical analysis:

        -  It is calculated that 52 patients will be needed for this study.

        -  Type I error probability associated with this test is 0.05 .

        -  Uncorrected chi square will be used to assess changes in the measured variables.
    
  